Sun Pharmaceutical Industries Ltd. closed 13.85% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on ...

However, nearly 10% of reports only disclosed activities in tax havens, according to the Fair Tax Foundation; in other news, ...

Sun Pharmaceutical Industries Ltd. closed 13.94% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Nagaraj Shetti of HDFC Securities recommends these two stocks to buy in the short-term - Bajaj Finserv Ltd, and Sun ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

Sun Pharma to invest $100 million in speciality products, targeting growth in innovative treatments for the future.

Sun Pharma's shares experienced a 0.47 per cent decline, trading at Rs 1,659.80, alongside the sharper fall in SPARC shares ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India's largest listed pharma company, ...